对实验诱导的二次过敏性进行药理学方法的系统审查和元分析
Gillian J Bedwell1, Luyanduthando Mqadi1, Romy Parker1
1African Pain Research Initiative, Department of Anaesthesia and Perioperative Medicine, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Pain
|August 21, 2025
概括
针对特定疼痛途径的药物治疗可以减少二次过敏. 阿尔法- 2 - 联体,NMDA受体对抗剂和通道阻断剂在控制疼痛的扩散和强度方面具有潜力.
科学领域:
- 神经科学
- 药理学
- 疼痛研究
背景情况:
- 持续的疼痛涉及复杂的生理机制,
- 有效的治疗策略需要深入了解疼痛生理学.
研究的目的:
- 系统地审查和分析药物干预对实验诱导的二次过敏的影响.
- 评估药物机制对过敏症的大小和表面积的影响.
主要方法:
- 按照科克兰指南进行系统审查和元分析.
- 电子文献搜索于2024年2月7日进行,包括117篇文章 (222个数据集).
- 基于药物机制和结果的标准化平均差异 (SMD) 的聚合效应大小.
主要成果:
- 二次过敏的数量和表面积都减少了.
- N-甲基-D-酸盐受体抗剂和电压通阻剂主要降低了表面积.
- 由于大多数数据集中对盲目处理程序的报告不足,因此存在偏差风险.
结论:
- 某些药物类别在调节二次过敏方面表现出有效性.
- 需要进一步研究以阐明大小和表面积在过敏症中的不同生理作用.
- 对患有持续疼痛的患者来说,明确大小与传播的临床相关性至关重要.
相关概念视频
01:30Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
01:27Allergic Drug Reactions
978
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
978
01:20Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
02:06Allergic Reactions
28.6K
Overview
28.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453